Skip to main content
. 2021 Mar 11;10(2):334–344. doi: 10.1093/toxres/tfab008

Figure 1.

Figure 1

The effects of gefitinib on body weight changes and survival rate in C57BL/6 and FVB/N mice. The body weight (A, B) and survival rate (C, D) of C57BL/6 mice and FVB/N mice were recorded every 7 days, treated without (saline) or with gefitinib (37.5 mg/kg, 75 mg/kg and 150 mg/kg of body weight, n≥4, apart from the FVB/N in 150 mg/kg after 35 days, n=2). Data were analyzed using Two-way ANOVA and presented as the mean ± SEM. Compared with control, *p < 0.05, **p < 0.01, ***p < 0.001.